← Open Payments lookup

JEREMY KELLEY: Open Payments

NPI 1952557498 · DEMOPOLIS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,288 in 112 payments from 17 companies in 2025. Trend: 2023 $3,044 · 2024 $2,644 · 2025 $2,288

Long term medical supply or device loan: $1,200Food & beverage: $1,088
CompanyPaymentsAmount
AngioDynamics, Inc.1$1,200
Novartis Pharmaceuticals Corporation63$224
United Therapeutics Corporation6$160
PFIZER INC.9$155
Actelion Pharmaceuticals US, Inc.6$114
Novo Nordisk Inc5$82
Amgen Inc.5$81
Merck Sharp & Dohme LLC5$78
E.R. Squibb & Sons, L.L.C.3$49
Alnylam Pharmaceuticals Inc.2$36

Products named: VenaCure 1470 Pro, LEQVIO, VYNDAQEL, Tyvaso, UPTRAVI, Wegovy, REPATHA, VERQUVO.

Industry payments across AL — which companies pay providers there.